Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Micromet starts mid-stage trial of leukemia treatment blinatumomab, its most advanced drug
Yahoo/AP
Tuesday, November 29, 2011 - 8:41am
tags:
blinatumomab, Micromet, leukemia
FDA clears $60M BioMarin drug-making plant expansion
Bizjournals.com
Tuesday, November 29, 2011 - 8:32am
tags:
FDA, Biomarin
5 Biotechs Posting Big Gains
Motley Fool
Tuesday, November 29, 2011 - 8:30am
tags:
ONYX Pharmaceuticals, Momenta, Micromet, Avanir, Arena Pharmaceuticals
Onyx Pharmaceuticals Said to Weigh Sale as It Explores Strategic Options
Bloomberg
Tuesday, November 29, 2011 - 8:24am
tags:
ONYX Pharmaceuticals, Nexavar, M&A, Carfilzomib
AZ bolsters VC arm with $100 million, buys into Australian firm
Pharma Times, UK
Tuesday, November 29, 2011 - 8:22am
tags:
venture capital, AstraZeneca, Australia, NeuProject, MedImmune Ventures
Bristol-Pfizer drug gets FDA priority review
Reuters
Tuesday, November 29, 2011 - 8:20am
tags:
Pfizer, FDA, Bristol-Myers Squibb, anticlotting, Eliquis
Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug
Bloomberg
Monday, November 28, 2011 - 4:47pm
tags:
Seattle Genetics, Hodgkin's lymphoma, Adcetris
Onyx Pharmaceuticals said to consider sale: report
Marketwatch
Monday, November 28, 2011 - 4:46pm
tags:
ONYX Pharmaceuticals, M&A
Pfizer's Xalkori: The Story Can Only Get Better
Seeking Alpha
Monday, November 28, 2011 - 4:44pm
tags:
Pfizer, Xalkori, lung cancer
Facebook apologizes for Merck homepage mix-up
Reuters
Monday, November 28, 2011 - 4:42pm
tags:
Facebook, Merck, social media, Merck KGaA
Pfizer's Tanezumab Research Setback Cannot Stop A Strong Investment
Seeking Alpha
Monday, November 28, 2011 - 4:32pm
tags:
Pfizer, tanezumab, osteoarthritis
Countdown to Generic Lipitor: Atorvastatin By Any Other Name
WSJ Online
Monday, November 28, 2011 - 11:57am
tags:
Lipitor, atorvastatin, Pfizer, generics, statins
Developer looks to nanoparticles for smoking cessation vaccine
Fierce Biotech
Monday, November 28, 2011 - 11:48am
tags:
nanoparticles, smoking cessation, Selecta
Supreme Court will hear sales-rep overtime dispute
Fierce Pharma
Monday, November 28, 2011 - 11:46am
tags:
overtime lawsuits, Supreme Court, GSK, drug reps
Regeneron Pharma and Bayer begin late-stage trial of eye drug Eylea in China
Yahoo/AP
Monday, November 28, 2011 - 11:41am
tags:
Regeneron, Bayer, Eyelea, China, retinal disease
Oncothyreon: $31 For Shares? Don't Believe The Hype
Seeking Alpha
Monday, November 28, 2011 - 11:40am
tags:
Oncothyreon
Pozen sells Treximet royalty rights for $75M
Yahoo/AP
Monday, November 28, 2011 - 11:39am
tags:
Pozen, Treximet
Gilead's Pharmasset Purchase Could Help Double Market Cap By 2020
Seeking Alpha
Monday, November 28, 2011 - 11:38am
tags:
Gilead, Pharmasset, M&A, hepatitis C, GSK, JNJ, Bristol-Myers Squibb, PSI-7977, Vertex, HIV
AstraZeneca Victory Over Iressa Labeling Is Appealed
Pharmalot
Monday, November 28, 2011 - 9:57am
tags:
AstraZeneca, Iressa, lung cancer
Abbott expands agreement with GSK to include additional cancer immunotherapy
Yahoo/Fly on the Wall
Monday, November 28, 2011 - 9:55am
tags:
Abbott Laboratories, GSK, cancer immunotherapy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.